Glaucoma Fellowship

What Glaucoma Fellows Actually Do Day-to-Day

A typical glaucoma fellowship week is anchored in high-volume clinic. Expect to see a large panel of patients in various stages of a disease that, for most of them, will never be cured—only slowed. Each encounter is a data synthesis problem: intraocular pressure trends, structural OCT progression, visual field reliability and progression algorithms, corneal pachymetry, and functional status. The cognitive load is real and sustained, because you are making treatment escalation decisions based on probabilistic signals, not binary test results.

Surgery punctuates the week rather than defining it. The operative repertoire spans a wide range of complexity and risk. Trabeculectomy with antifibrotics remains the benchmark for IOP reduction and demands meticulous tissue handling and postoperative wound titration—bleb management continues for months. Tube shunt implantation (Baerveldt and Ahmed devices) involves longer cases with more anatomical variables and carries distinct complication profiles. Cyclophotocoagulation (transscleral or endoscopic) is reserved for specific clinical contexts. At the less invasive end, microinvasive glaucoma surgery (MIGS)—iStent, OMNI, Kahook Dual Blade, and others—has substantially expanded the surgical middle ground and is frequently combined with cataract surgery, which means coordination with a patient's comprehensive ophthalmologist is common.

Laser procedures, particularly selective laser trabeculoplasty (SLT), are performed regularly and often serve as a first-line treatment step before or instead of drops. Fellows become facile with this in the first months.

The less-discussed portion of the week is postoperative bleb management: titrating antifibrotics, needling failing trabeculectomies, and managing hypotony. This is skilled, iterative work that extends your relationship with a surgical outcome over weeks to months. If you want to operate and move on, glaucoma's prolonged surgical aftercare will frustrate you. If you find iterative optimization satisfying, it fits naturally.

The Glaucoma Personality Profile

Glaucoma subspecialists consistently share a specific cognitive style: they are comfortable making decisions under uncertainty and are not destabilized when the "right answer" is a range rather than a number. The disease forces this. IOP targets are individualized and provisional. Optic nerve photographs from two years apart may show change that is real, artifact, or borderline—and you have to act anyway. Structural and functional data frequently dissociate, and reconciling them requires probabilistic reasoning, not lookup-table medicine.

Longitudinal relationship comfort is non-negotiable. Most glaucoma patients follow with you for years or decades. You will know their baselines better than they do. You will have difficult conversations about functional decline, medication burden, and surgical risk with people who may be entirely asymptomatic and therefore skeptical. Motivating adherence without alarming a patient who feels fine is a distinct communication skill, and it recurs constantly.

Tolerance for slow-moving disease is distinct from intellectual passivity. The satisfaction in glaucoma comes from catching a progression trend early, adjusting treatment, and confirming stabilization on serial testing—a feedback loop that operates on a timescale of months to years, not minutes to days. Fellows who thrive here tend to describe this as deeply satisfying. Those who struggle describe it as unrewarding.

Finally, genuine interest in imaging interpretation and data is a practical prerequisite. OCT-RNFL, Bruch's membrane opening-minimum rim width, Humphrey visual field pattern deviation and trend analyses, GPA printouts—these are the instruments of daily practice. You do not have to have trained as a statistician, but you need to find this material interesting enough to stay current as the tools evolve.

Core Procedural Skills You Must Genuinely Enjoy

Before committing to a glaucoma track, conduct an honest audit of your procedural enthusiasm, not just competence. Being technically capable and genuinely enjoying a procedure are different things, and glaucoma will ask you to perform these repeatedly throughout a career.

Trabeculectomy with antifibrotics (MMC or 5-FU): The foundational glaucoma operation. Requires precise conjunctival and scleral flap dissection, controlled antifibrotic application, and nuanced postoperative management. Technically demanding, with a long tail of follow-up care. If you find conjunctival surgery tedious, that matters.
Tube shunt implantation (Baerveldt, Ahmed): Longer, anatomically variable cases with distinct failure modes. Revision procedures are common over a patient's lifetime. Strong spatial reasoning and comfort with hardware-implant decisions required.
MIGS devices: Gonioscopically guided, angle-based procedures. Require mastery of intraoperative gonioscopy—a skill that takes deliberate time to build and that many comprehensive ophthalmology residents underuse. The MIGS space is actively evolving, and new devices reach practice with regularity. This suits people who like to stay current technically.
Selective laser trabeculoplasty (SLT): Office-based, low-risk, high-frequency. Not technically demanding but requires appropriate patient selection and management of expectations. Repeatable and increasingly positioned as first-line, which gives you ongoing longitudinal responsibility for the outcome.
Cyclophotocoagulation (transscleral CPC, endoscopic ECP): Used in more advanced or refractory disease. ECP requires facility with intraocular endoscopy. Less glamorous technically but important to master for the full patient spectrum.
Bleb management and needling: Not glamorous, frequently underemphasized in residency, but a significant proportion of glaucoma surgical follow-up. Comfort with office-based needling procedures and antifibrotic injections is essential.

Self-assessment prompt: At the end of your glaucoma rotation, identify the two procedures you most wanted to do again and the two you hoped not to see on the schedule. That honest inventory is more informative than any checklist.

How Glaucoma Differs From Other Ophthalmic Subspecialties

Understanding glaucoma's texture requires triangulating it against the other fellowships you are implicitly not choosing.

Versus retina: Retina shares glaucoma's chronic disease management burden and imaging intensity, but the feedback loop is faster—intravitreal injections produce visible anatomical response within weeks, and surgical outcomes (for tractional or rhegmatogenous disease) are more immediately legible. Retina also offers a broader scope of acute pathology. Glaucoma has less acute volume and a narrower structural focus. Retina fellowship training tends to be longer and carries heavier call burden, particularly in academic or county settings.

Versus cornea: Cornea is more visual rehabilitation–oriented; successful outcomes restore or dramatically improve vision. Glaucoma preserves vision that the patient may not yet be aware they are losing. The emotional register is different: cornea patients often present symptomatic and leave grateful for improvement. Glaucoma patients often present well and leave unchanged—which is success, but requires explaining that to patients. Cornea fellowship also produces a more distinct set of procedural skills (DSEK, DMEK, PKP, anterior segment reconstruction) and a closer relationship with refractive surgery.

Versus oculoplastics: Oculoplastics operates at the intersection of ophthalmology and plastic surgery, with strong functional-cosmetic duality. Case variety is high, anatomical territory is broader (orbit, lacrimal system, eyelids), and the operative aesthetic demands differ substantially from glaucoma. Oculoplastics practice has a shorter longitudinal patient relationship per episode of care. If you are drawn to reconstructive or cosmetic dimensions, the overlap with glaucoma is minimal.

Versus pediatric ophthalmology: Pediatric fellowship includes strabismus surgery and management of conditions spanning many subspecialty domains in smaller bodies. Congenital glaucoma exists and is managed in pediatric or glaucoma fellowships depending on the program, but the general pediatric ophthalmology experience is more surgically varied and relationship-intensive in a different way—family dynamics, development, amblyopia management. The career trajectory and practice structure differ substantially from adult glaucoma.

The common thread that distinguishes glaucoma from most ophthalmic subspecialties: you are primarily a disease-stabilizer, not a disease-resolver. If the gratification of ophthalmology for you is restoring a patient's vision through a decisive intervention, glaucoma will satisfy that drive only intermittently. If the gratification is preventing a patient from going blind over twenty years of careful stewardship, glaucoma offers that in abundance.

Signs This Fellowship May Not Be For You

These are patterns observed in trainees who match into glaucoma and then find it misaligned—worth examining before committing to the application cycle.

You find chronic disease management inherently less interesting than episodic, intervention-centered care. If you want to solve a problem and transition the patient out of your care, most glaucoma patients will not give you that.
You want faster surgical feedback loops. Trabeculectomy outcomes are evaluated over weeks to months. Tube shunt function is assessed for years. If you need to know by the first postoperative day whether surgery succeeded, glaucoma's timeline will be a source of ongoing frustration.
You are primarily motivated by visual rehabilitation—returning vision to patients who have lost it. Glaucoma damage is irreversible. Your therapeutic wins are measured in decibels of visual field that did not deteriorate. Some find this profoundly meaningful; others find it emotionally unsatisfying over time.
You dislike imaging-heavy workflows. If reviewing serial OCT stacks, reconciling structural-functional discordance, and spending significant clinic time on test interpretation sounds like administrative overhead rather than clinical substance, glaucoma will feel like the wrong specialty from day one.
You are drawn to a practice model with minimal long-term patient retention. High-volume surgical-only practice is possible in glaucoma but is not the norm, and the foundational work of the field is longitudinal management.
Your surgical enthusiasm is primarily for complex anterior segment reconstruction or posterior segment work. Glaucoma surgery is anatomically specific; if you find the cornea, lens, or retina more compelling operatively, follow that signal.

Signs You Are a Natural Fit

You find optic nerve structural analysis genuinely interesting—you stop at the disc photos in clinic not because you have to but because you want to. The architecture of the neuroretinal rim, the quality of RNFL loss patterns, and the correlation with visual field defects hold your attention.
You derive satisfaction from disease stabilization as an outcome. When a patient's visual fields are unchanged after three years of careful management, that registers for you as a real win, not an absence of progress.
You are comfortable with surgical reoperation as a normal feature of practice, not a failure signal. Glaucoma surgery has known and manageable failure rates; needling, revision, and progression to a second procedure are expected clinical events. Practitioners who experience reoperation as demoralizing will burn out in this field.
You are interested in the MIGS innovation pipeline. The device ecosystem is genuinely active, with clinical trials, evolving indications, and the downstream question of how subspecialists versus comprehensive ophthalmologists will divide this work. If you want to be at that frontier, glaucoma fellowship positions you well.
You feel drawn to the specific patient population—older adults, a disease that disproportionately affects Black and Hispanic patients, and the health equity dimensions of care access in a condition that is asymptomatic until late. If those clinical and public health dimensions feel like reasons to be in the room, not complications of practice, that is a meaningful signal.
You like the problem structure of glaucoma: imperfect tests, probabilistic signals, individualized targets, no single correct answer. If that structure energizes rather than frustrates you, the daily cognitive experience will suit you.
You want a career that is sustainable from a call and lifestyle standpoint without sacrificing subspecialty depth. Glaucoma, relative to retina, tends toward manageable call burden—though this varies significantly by setting.

Research and Academic Landscape in Glaucoma

Glaucoma has a robust and genuinely active research base. If academic medicine is your goal, understanding the domain landscape helps you identify where to position during fellowship and early faculty years.

Neuroprotection: The fundamental unsolved problem in glaucoma is that IOP-lowering prevents progression but does not restore lost retinal ganglion cells. Neuroprotective and neuroregenerative strategies—small molecules, gene therapy, optogenetics—are the subject of ongoing basic science and translational work. If you have a neuroscience or cell biology background, this is a tractable academic entry point.

MIGS device trials: Clinical trials evaluating new devices and combinations are actively enrolling, and academic glaucoma programs are frequent sites. Fellow involvement in trial coordination and data analysis is common. This is a practical route to early publications and IRB experience.

AI-based progression detection: Machine learning applied to OCT, fundus photography, and visual field data is an active area, with several groups working on improving sensitivity and specificity of early progression detection. If you have quantitative skills, this is a high-output research domain with growing industry partnership.

Genetics and precision medicine: Glaucoma genetics, particularly for normal-tension, juvenile-onset, and high-pressure subtypes, is an evolving field. Translational programs linking genetic risk profiles to clinical management are developing at major academic centers.

Health equity research: The disproportionate burden of glaucoma in Black and Hispanic populations is well documented, and research into access to care, screening uptake, treatment adherence, and outcomes disparities is a substantial and fundable area. Clinical researchers with community-based practice exposure are well positioned here.

For private practice ambitions, research engagement is less central, but familiarity with MIGS trial data, evidence-based prescribing, and outcomes literature remains competitive differentiators. Private practice glaucoma in an academic-adjacent or large group setting increasingly expects fellows to arrive with surgical readiness and some research literacy, even without publication expectations.

Patient Population and Relationship Dynamics

Glaucoma's patient population has a specific demographic profile that shapes the emotional and cultural texture of practice in ways worth understanding before you commit.

The majority of glaucoma patients are older adults. Primary open-angle glaucoma prevalence rises substantially with age, and much of your clinic volume will be in the sixty-and-above range. Long-term relationships develop naturally, and you will navigate cognitive decline, polypharmacy, and functional vision needs in the context of broader aging. Comfort with geriatric communication and care coordination is a practical skill, not a peripheral nicety.

Glaucoma disproportionately affects Black Americans and Hispanic Americans, at higher prevalence and often at greater severity at presentation. This is not a footnote—it is a defining feature of the practice. Fellows who have reflected on structural drivers of late presentation, barriers to adherence, and how to build trust across cultural differences will be better practitioners. Programs at safety-net institutions or urban academic centers will surface these dynamics more intensively, but the epidemiology follows you regardless of practice setting.

The asymptomatic nature of glaucoma until late-stage disease creates a persistent communication challenge. Patients often do not feel sick, do not experience their vision as compromised, and may struggle to understand why they need lifelong medications or surgery. Communicating the stakes of non-adherence in a way that motivates without causing unnecessary anxiety is a clinical skill that takes deliberate practice. Fellows who underinvest in this dimension tend to see it appear in their patient outcomes data years later.

The emotional weight of the work is real. You will have patients who present late and who you cannot restore. You will have patients who adhere perfectly and progress anyway. And you will have patients who, through twenty years of consistent follow-up, reach late life with functional vision intact—a quiet, sustained success that is deeply specific to this field.

Work-Life and Practice Structure Realities

Glaucoma practice structure varies enough between settings that broad generalizations are misleading—but several patterns hold.

Call burden in glaucoma is generally lower than in retina or cornea, and true middle-of-the-night emergencies are uncommon. Acute angle closure is the notable exception and requires prompt management, but it is not the daily reality of a glaucoma practice. This matters for career sustainability, especially for those planning for family or managing other life commitments.

Surgical volume depends heavily on setting. Academic programs serving large referral bases and safety-net populations will provide higher-complexity surgical volume, more trabeculectomies and tube shunts, and broader exposure to refractory cases. Private or community practice glaucoma may skew more toward MIGS, laser, and medical management, with selective referral of the most complex cases. Neither is inherently better, but they produce different career trajectories and different skills profiles over time. Know which you are entering.

MIGS has meaningfully complicated the boundary between glaucoma subspecialists and comprehensive ophthalmologists. A growing number of comprehensive ophthalmologists perform iStent or similar MIGS devices at the time of cataract surgery, which affects the case mix available to fellowship-trained specialists. Glaucoma fellows entering practice should have a clear view of how this is playing out in their target market—whether the trend concentrates more complex cases in subspecialists' hands or compresses the referral base. This varies by region and is worth direct inquiry during fellowship interviews and early job searches.

Partnership tracks and compensation models vary widely across practice types. For current data on compensation ranges and practice structure benchmarks, see the site's specialty data pages—these figures shift with practice consolidation and payer mix changes, and inline numbers would be stale within a cycle.

Fellowship Program Landscape and What Programs Look For

There are approximately fifty ACGME-accredited glaucoma fellowship programs in the United States as of recent accreditation cycles, nearly all structured as one-year positions. The majority of positions are filled through the SF Match glaucoma fellowship match, with applications, interviews, and rank lists following a cycle that runs during the PGY-3 or PGY-4 year depending on your residency structure. See the current season timeline on this site for cycle-specific dates.

What program directors evaluate, in rough priority order based on publicly available program descriptions and the structure of the field:

Surgical readiness: Glaucoma fellowship is one year. Programs cannot build basic surgical proficiency from scratch. They need residents who arrive with a solid phacoemulsification foundation and ideally some exposure to glaucoma procedures. Demonstrating operative competence in your application—case logs, specific mention from your letter writers—matters.
Letters from glaucoma attendings specifically: A letter from your program director is expected. A letter from a glaucoma subspecialist who has directly observed your surgery, your clinical reasoning, and your patient interactions is weighted heavily. If your residency has a glaucoma faculty member, cultivating that relationship in PGY-2 or PGY-3 is a concrete application investment.
Research engagement: Not universally required, but programs with strong academic missions weight it. A completed glaucoma-adjacent project—even a case series, outcomes audit, or systematic review—demonstrates investment in the field and capacity for fellowship-level intellectual work. Abstract presentations at AAO or ARVO carry signal.
Professionalism and interpersonal fit: Fellowship programs are small communities. The interview process is partly an assessment of whether you will function well in a high-contact, year-long training relationship with a small faculty. References to collegiality, communication, and work ethic in your letters matter more in this context than in a residency application.
Genuine interest in glaucoma specifically: Program directors speak regularly to each other. Generic applications that read as fallback choices are identifiable. Having a coherent narrative—a rotation that changed your thinking, a specific clinical or research question, a patient encounter that crystallized your interest—is not optional packaging; it is expected evidence of a real career decision.

How to Test Your Fit During Residency

Fit decisions made without direct evidence are guesses. Here are the specific steps available during PGY-2 through PGY-4 to gather real data about your alignment with glaucoma.

Request protected time on the glaucoma service early, not late. PGY-2 is not too early. The goal is to observe the texture of practice—patient interactions, imaging reviews, bleb checks, laser days—before you have developed a fixed opinion about what you want. Early exposure gives you more time to revise and more clinical experiences to reference in applications.
Track your subjective response to different procedure types. Keep an informal log of which procedures you looked forward to and which you found tedious. This is not about competence—you will get competent at all of them. It is about genuine interest, which is the only reliable predictor of career satisfaction across decades.
Have an honest conversation with the glaucoma attendings at your program about your fit, not just your interest. Attendings who train fellows have a calibrated sense of what the fellowship and career demand. Ask them what trainees who struggle in glaucoma usually struggle with. That answer is more useful than encouragement.
Read one or two foundational glaucoma papers outside of required curriculum. If you find yourself going further—reading the citations, looking up the device trials, wanting to understand the neuroprotection mechanism—that pull is signal. If assigned reading feels like a chore in a way that other subspecialty reading does not, that is signal too.
Attend glaucoma-focused sessions at AAO or regional meetings. The talk content, the questions from the audience, and the type of practitioners in the room will give you a concrete sense of the intellectual community you would be joining.
If possible, do an away rotation at a program whose fellowship culture interests you. Away rotations in ophthalmology fellowship are less universal than in some other fields, but they exist and are valuable both for fit assessment and for application visibility.
Identify a mentor who will give you direct feedback on your candidacy. This person should be someone who has seen your surgery, interacts with glaucoma fellowship program directors, and will tell you honestly if your application is competitive and where to strengthen it.

Questions to Ask Current Fellows and Attendings

Generic program questions produce marketing answers. The questions below are designed to elicit operational reality. Use them in informal conversations, not formal interview settings where program evaluation dynamics apply.

"What is the ratio of clinic to OR days in a typical week, and how does that change across the fellowship year?" — Reveals whether surgical exposure is front-loaded or evenly distributed, and whether clinic burden crowds out operative experience.
"How often do fellows perform trabeculectomies as primary surgeon versus assisting? Same question for tube shunts." — The only metric that matters for surgical training is how often you hold the instruments with genuine responsibility. Assist counts inflate on paper.
"How does the program handle complications during cases you are leading?" — Reveals the actual autonomy-safety balance and whether fellows get bailed out so fast they never learn to manage trouble.
"What does bleb management look like here—who does the needling, and how much of that falls to the fellow?" — Tests whether postoperative teaching is real or delegated back to staff.
"What are former fellows actually doing two years out—academic faculty, private group, solo?" — Outcome data is the most reliable proxy for program strength. Programs that lose track of graduates rarely have strong mentorship cultures.
"What does a fellow do when they disagree with an attending's management decision?" — A behavioral question dressed as a structural one. The answer reveals the program's intellectual culture and tolerance for trainee reasoning.
"Is there protected research time? What have fellows published from this program in the last three years?" — Separates programs that list research as a feature from those that actually produce it.
"How has MIGS changed case referral patterns here—do you see more or fewer complex surgical cases than five years ago?" — Surfaces whether the program has adapted to market shifts or is watching its case complexity erode.
"What do fellows find hardest in the first three months?" — Reveals genuine transition challenges. Answers that sound like marketing copy ("Oh, just adjusting to the volume!") indicate a program that does not reflect carefully on training gaps.
"What clinical question do you wish the field had answered by now?" — For attendings particularly. The quality and depth of the answer tells you about intellectual engagement and where the faculty is positioned in the research community.
"How is call structured, and what kinds of cases actually come in after hours?" — Practice structure transparency. Compare across programs to calibrate what is genuinely typical versus outlier.
"If you had to identify one thing this program does not do well, what would it be?" — The only direct question that predictably generates honest information. Fellows who have been in the program six or more months will usually answer this one truthfully.

Making the Decision: A Personal Fit Checklist

Work through each item honestly. The goal is not a score—it is to surface where your uncertainty is concentrated so you can gather more evidence before the application cycle, not after.

Clinical and cognitive fit

☐ I find optic nerve and OCT interpretation genuinely interesting, not just acceptable.

☐ I am comfortable making treatment decisions from probabilistic, imperfect data without being destabilized by ambiguity.

☐ Preventing disease progression satisfies me as an outcome, even when no visible improvement occurs.

☐ I am comfortable with chronic disease management as the dominant mode of practice.

☐ I find the intellectual texture of glaucoma—imaging, progression analysis, target-setting—more engaging than the procedural texture of retina, cornea, or anterior segment reconstruction.

Surgical fit

☐ I want to perform trabeculectomy and tube shunts as a core part of my career, not as an occasional fallback.

☐ I accept that surgical outcomes in glaucoma have longer, less legible feedback loops than most ophthalmic operations.

☐ Reoperation and bleb management strike me as interesting clinical problems, not failure states.

☐ I am genuinely interested in the MIGS device space and want to stay technically current as it evolves.

Patient population fit

☐ I am drawn to long-term patient relationships spanning years to decades.

☐ I am prepared to care for patients who are asymptomatic and require significant motivation and education to adhere to treatment.

☐ The health equity dimensions of glaucoma—its disproportionate burden in specific communities—feel like a reason to be in this field, not a complexity to manage.

Career and practice fit

☐ My practice structure preferences (academic, private group, community) are compatible with a realistic glaucoma case mix in that setting.

☐ I have a clear-eyed view of how MIGS is shifting the boundary between glaucoma subspecialists and comprehensive ophthalmologists in the markets I am considering.

☐ I have spoken with at least one glaucoma fellow and one practicing subspecialist about what they find hardest about the career—not just what they love about it.

Evidence gathered during residency

☐ I have had at least one substantive glaucoma rotation and tracked my genuine reactions to the work.

☐ At least one glaucoma attending who has seen my surgery has given me direct, specific feedback on my surgical readiness and fit for the fellowship.

☐ I can articulate a specific clinical or research question in glaucoma that I find compelling—not because it answers well in an interview, but because it is actually true.

If you reached the end of this checklist with more checkmarks than blanks and no item that prompted a strong negative reaction, glaucoma fellowship is likely worth a serious application. If several items in the clinical or surgical fit section are genuinely unresolved—not unsure because of limited exposure, but unsure because the work you have seen did not draw you in—that is meaningful data. Get more exposure before you apply, or reexamine whether a different subspecialty aligns better with how you actually think and what you actually want from a career.